Overview
- 12 FDA inspections are on record.
- 7 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-05-13.
At a glance
Inspections
12
Form 483s
7
EIRs
1
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 1 May 2025 – 13 May 2025 | Human Drugs | 483 | View 483 → |
| 28 Oct 2024 – 1 Nov 2024 | Human Drugs | Clean | |
| 29 Apr 2024 – 2 May 2024 | Human Drugs | Clean | |
| 3 Jun 2022 – 10 Jun 2022 | Human Drugs | 483 | On file |
| 16 Jan 2020 – 24 Jan 2020 | Human Drugs | Clean | |
| 1 Oct 2019 – 4 Oct 2019 | Human Drugs | Clean | |
| 3 Jan 2018 – 5 Jan 2018 | Human Drugs | Clean | |
| 19 Apr 2017 – 1 May 2017 | Human Drugs | 483 | View 483 → |
| 27 May 2015 – 9 Jun 2015 | Human Drugs | 483 | View 483 → |
| 6 Mar 2013 – 20 Mar 2013 | Human Drugs | 483 | View 483 → |
| 19 Jul 2011 | Not recorded | 483 | View 483 → |
| 19 May 2011 | Not recorded | 483 | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
9 Jun 2015
21 CFR 211.100(b)
Procedure Deviations Recorded and Justified
Cited by Christopher R Czajka, Anita Narula
9 Jun 2015
21 CFR 211.160(a)
Following/documenting laboratory controls
Cited by Christopher R Czajka, Anita Narula
Investigators
FDA investigators tied to this site in the record.
Anita Narula4 insp.
Christopher R Czajka3 insp.
Veronica L Bush1 insp.
Roger F Zabinski1 insp.
Wendy G Tan1 insp.
Jacek Cieslak1 insp.
Kenneth O Gee1 insp.
Mark W Babbitt1 insp.
Sangeeta M Khurana1 insp.
Joshua P Wireman1 insp.
Eric L Dong1 insp.
Barbara J Breithaupt1 insp.
Maria P Kelly-Doggett1 insp.
Mary E Farbman1 insp.
Heika R Tait1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.180(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.198(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 312.50 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.80(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 314.80(c)(1)(i) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 600.80(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 600.80(c)(1)(i) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind SEAGEN INC.'s 7 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat